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Background

Among the cancers that routinely afflict
the aerodigestive tract, oropharyngeal
squamous cell carcinoma is of particular
importance due to its higher rate of increasing
incidence. It is evidenced that this annual
2.5% increase is due in part by the adjunct
infection with Human papillomavirus
(HPV) which induces oncogenic and molecular
modifications. An epigenome-wide association
(EWAS) study was recently performed on
DNA methylation in peripheral blood
leukocytes in 20 pairs of HPV (+) and HPV (-)
OPSCC cells. It showed leukocyte DNA
in HPV (+) patients to have a hypomethylated
pattern in comparison to HPV (-) patients. In
contrast, a non-coding RNA, nc886, was most
significantly hypermethylated in HPV (+)
patients. However, it remains undetermined the
distinct epigenetic exchange occurring between
suspect methylation patterns and the presence
of nc886. The aim of this study is to decode the
genetic interplay potentially involved between
DNA methylation and HPV-induced
oropharyngeal carcinogenesis.

Results
Figure 1. qRT-PCR analysis of forced nc886 expression

Conclusions/Implications
Figure 2. Western Blot analyses of PKR expression in over-

expressed nc886 cells. Equal proportions of protein concentrations
were added to all wells, and the presence of PKR was detected with
monoclonal antibody GAPDH. GAPDH was detected as a loading
control. Comparison of PKR and pPKR demonstrates differential
kinase activity patterns

•

•
Figure 3. Flow cytometry data obtained from a representative sample is shown. Cells of the FaDu cell line

were first gated based on apoptosis (Annexin V-FITC). Necrotic cells in the whole blood sample were detected
by Propidium Iodine (PI) staining. (a) pcDNA3.1 control FaDu. (b) High expression of nc886 FaDu. (c)siRNA
control FaDu. (d) nc886 and siRNA FaDu.

•

Hypothesis
(a)

If the novel non-coding RNA, nc886, is
involved in HPV-induced OPSCC
etiology such that there is an epigenetic
mechanism occurring between HPV
oncogenes and nc886, then
overexpression and gene knockout of
nc886 will affect the propensity of
OPSCC cell proliferation, migration, and
metastasis via its down regulatory
relationship with Protein Kinase R
phosphorylation.

(b)

(c)

(d)

Figure 4. nc886 knockout leads to cell death in FaDu. (A) The flow chart of CRISPR/Cas9 homology directed repair (HDR).
(B) Gene modification detected in nc886 sequence area of GFP+ cells. Those cells died soon after moving out from 96-well
plate. (C) GFP detection of the FaDu nc886 KO candidates by fluorescence microscopy.

Methods
• HPV negative OPSCC cells of the FaDu cell line
were transfected with HPV E6/E7 (oncogenic
proteins) via lentiviral transfection
• Transfected cells were isolated via
ultracentrifugation and filtration
• CRISPR/Cas9 along with single guide
RNA(sgRNA) technology was applied to
knockout nc886 in targeted OPSCC cells
• siRNA technology was utilized to
knockdown gene expression
• Methylation sequencing, qRT-PCR, flow
cytometry, and Western blot were utilized to
analyze the phenotypic effects of nc886 silencing
and overexpression on cell growth, proliferation,
and PKR phosphorylation

•

Differential nc886 expression
patterns in patient samples may be
indicative of cell stability,
apoptotic resistance, and relevant
to cancer prognosis and
intervention.
PKR expression and kinase
activity may be directly correlated
to levels of nc886 present,
potentially linking phosphorylation
and cell proliferation to signature
markers of cancer etiology.
Function of nc886 may influence
cell survival and cancer regulatory
mechanisms as implicated via gene
knockout of nc886 in GFP (+)
cells.
The implications of this study
should yield the first evidenced
event that two prominent
epigenetic events (DNA
methylation and non-coding RNA
regulation) can synchronize to
initiate HPV-induced modulations
in the onset and progression of
oropharyngeal cancers.
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